MFW
IMMU

Meristem Family Wealth’s Immunomedics Inc IMMU Stock Holding History

Meristem Family Wealth’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,786
Closed -$40K – 113
2016
Q4 		$40K Buy
+10,786
New +$31.9K 0.02% 106

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Meristem Family Wealth's IMMU Position: Q1 2017 in Review

Meristem Family Wealth sold out of Immunomedics Inc (IMMU) in Q1 2017, closing a stake of 10,786 shares — an estimated $40K sold.

Meristem Family Wealth first reported a position in IMMU in Q4 2016 and held it in 1 quarter. The position peaked at $40K in Q4 2016. 124 funds tracked by Wall St. Rank hold IMMU as of Q1 2017.

  • Meristem Family Wealth reported no remaining Immunomedics Inc position as of Q1 2017 after selling out during the quarter.
  • Meristem Family Wealth sold 10,786 Immunomedics Inc shares in Q1 2017, an estimated $40K.
  • Meristem Family Wealth first reported a position in Immunomedics Inc in Q4 2016 and held it in 1 quarter.
  • Meristem Family Wealth's Immunomedics Inc position peaked at $40K in Q4 2016.
  • 124 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2017.

Based on Meristem Family Wealth's 13F filing for Q1 2017, filed 8 May 2017.